Clinical Trial: Construction of Single-Cell Transcriptomic and Immune Receptor Repertoire Atlases of Carotid Atherosclerotic Plaques and Investigation of the Mechanisms Underlying Plaque Vulnerability (China)

Posted On: 2026-10-15

China, Oct. 15 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Construction of Single-Cell Transcriptomic and Immune Receptor Repertoire Atlases of Carotid Atherosclerotic Plaques and Investigation of the Mechanisms Underlying Plaque Vulnerability'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134428

Registration Time: 2026/10/14

Type: Observational study

Primary Sponsor: Peking Union Medical College Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=347614

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Construction of Single-Cell Transcriptomic and Immune Receptor Repertoire Atlases of Carotid Atherosclerotic Plaques and Investigation of the Mechanisms Underlying Plaque Vulnerability (China)